Atuka provides contract research and consultancy services for the biopharmaceutical industry with world-leading expertise in Parkinson’s disease and other neurological conditions. We combine cutting-edge pre-clinical rodent and primate efficacy testing including a comprehensive range of motor and non-motor assays (e.g. cognition and impulse control) with medicinal chemistry services, DMPK and in-vivo imaging in aiding the development of novel therapeutics and diagnostics.